167 related articles for article (PubMed ID: 26698323)
1. The Potential of Minipigs in the Development of Anticancer Therapeutics: Species Comparison and Examples of Special Applications.
Mahl A; Dincer Z; Heining P
Toxicol Pathol; 2016 Apr; 44(3):391-7. PubMed ID: 26698323
[TBL] [Abstract][Full Text] [Related]
2. The Use of Minipig in Drug Discovery and Development: Pros and Cons of Minipig Selection and Strategies to Use as a Preferred Nonrodent Species.
Heining P; Ruysschaert T
Toxicol Pathol; 2016 Apr; 44(3):467-73. PubMed ID: 26674804
[TBL] [Abstract][Full Text] [Related]
3. The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey.
Colleton C; Brewster D; Chester A; Clarke DO; Heining P; Olaharski A; Graziano M
Toxicol Pathol; 2016 Apr; 44(3):458-66. PubMed ID: 27006130
[TBL] [Abstract][Full Text] [Related]
4. The minipig as nonrodent species in toxicology--where are we now?
Ganderup NC; Harvey W; Mortensen JT; Harrouk W
Int J Toxicol; 2012; 31(6):507-28. PubMed ID: 23134714
[TBL] [Abstract][Full Text] [Related]
5. Swine as models in biomedical research and toxicology testing.
Swindle MM; Makin A; Herron AJ; Clubb FJ; Frazier KS
Vet Pathol; 2012 Mar; 49(2):344-56. PubMed ID: 21441112
[TBL] [Abstract][Full Text] [Related]
6. The minipig in toxicology.
Svendsen O
Exp Toxicol Pathol; 2006 Jul; 57(5-6):335-9. PubMed ID: 16725317
[TBL] [Abstract][Full Text] [Related]
7. Vehicle Systems and Excipients Used in Minipig Drug Development Studies.
Weaver ML; Grossi AB; Schützsack J; Parish J; Løgsted J; Bøgh IB; Cameron D; Harvey W; Festag M; Downes N; Venturella S; Schlichtiger J; Mhedhbi S; Ross V; Kissner T; Stark C; Milano S; Heining P; Sanchez-Felix M
Toxicol Pathol; 2016 Apr; 44(3):367-72. PubMed ID: 26674803
[TBL] [Abstract][Full Text] [Related]
8. Minipigs in Translational Immunosafety Sciences: A Perspective.
Rubic-Schneider T; Christen B; Brees D; Kammüller M
Toxicol Pathol; 2016 Apr; 44(3):315-24. PubMed ID: 26839327
[TBL] [Abstract][Full Text] [Related]
9. Comparison of minipig, dog, monkey and human drug metabolism and disposition.
Dalgaard L
J Pharmacol Toxicol Methods; 2015; 74():80-92. PubMed ID: 25545337
[TBL] [Abstract][Full Text] [Related]
10. Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiative.
Descotes J; Allais L; Ancian P; Pedersen HD; Friry-Santini C; Iglesias A; Rubic-Schneider T; Skaggs H; Vestbjerg P
Regul Toxicol Pharmacol; 2018 Apr; 94():271-275. PubMed ID: 29481836
[TBL] [Abstract][Full Text] [Related]
11. Is Science the Only Driver in Species Selection? An Internal Study to Evaluate Compound Requirements in the Minipig Compared to the Dog in Preclinical Studies.
Schaefer K; Rensing S; Hillen H; Burkhardt JE; Germann PG
Toxicol Pathol; 2016 Apr; 44(3):474-9. PubMed ID: 26839331
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and Electroretinographic Characterization of the Minipig Eye in the Context of Drug Safety Investigations.
Negro Silva LF; Li C; de Seadi Pereira PJB; Tan W; Dubuc-Mageau M; Sanfacon A; Forster R; Tavcar R; Makin A; Authier S
Int J Toxicol; 2019; 38(5):415-422. PubMed ID: 31470746
[TBL] [Abstract][Full Text] [Related]
13. The importance of minipigs in dermal safety assessment: an overview.
Stricker-Krongrad A; Shoemake CR; Liu J; Brocksmith D; Bouchard G
Cutan Ocul Toxicol; 2017 Jun; 36(2):105-113. PubMed ID: 27161161
[TBL] [Abstract][Full Text] [Related]
14. The RETHINK project on minipigs in the toxicity testing of new medicines and chemicals: conclusions and recommendations.
Forster R; Bode G; Ellegaard L; van der Laan JW
J Pharmacol Toxicol Methods; 2010; 62(3):236-42. PubMed ID: 20685309
[TBL] [Abstract][Full Text] [Related]
15. Background Pathological Changes in Minipigs: A Comparison of the Incidence and Nature among Different Breeds and Populations of Minipigs.
Helke KL; Nelson KN; Sargeant AM; Jacob B; McKeag S; Haruna J; Vemireddi V; Greeley M; Brocksmith D; Navratil N; Stricker-Krongrad A; Hollinger C
Toxicol Pathol; 2016 Apr; 44(3):325-37. PubMed ID: 26534940
[TBL] [Abstract][Full Text] [Related]
16. Dermatotoxicology: Safety Evaluation of Topical Products in Minipigs: Study Designs and Practical Considerations.
Willard-Mack C; Ramani T; Auletta C
Toxicol Pathol; 2016 Apr; 44(3):382-90. PubMed ID: 26839328
[TBL] [Abstract][Full Text] [Related]
17. Pigs in Toxicology: Breed Differences in Metabolism and Background Findings.
Helke KL; Nelson KN; Sargeant AM; Jacob B; McKeag S; Haruna J; Vemireddi V; Greeley M; Brocksmith D; Navratil N; Stricker-Krongrad A; Hollinger C
Toxicol Pathol; 2016 Jun; 44(4):575-90. PubMed ID: 27044377
[TBL] [Abstract][Full Text] [Related]
18. Perspectives From the 12th Annual Minipig Research Forum: Early Inclusion of the Minipig in Safety Assessment Species Selection Should be the Standard Approach.
Jones K; Harding J; Makin A; Singh P; Jacobsen B; Mikkelsen LF
Toxicol Pathol; 2019 Oct; 47(7):891-895. PubMed ID: 31280706
[TBL] [Abstract][Full Text] [Related]
19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
20. Toxicological profile of IQG-607 after single and repeated oral administration in minipigs: An essential step towards phase I clinical trial.
Rodrigues-Junior VS; Cintra L; Machado P; Dadda A; Basso LA; Mafra ACCN; Campos AH; Campos MM; Santos DS
Regul Toxicol Pharmacol; 2017 Nov; 90():78-86. PubMed ID: 28838610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
